1.广州中医药大学第一附属医院,广州 510400
2.广州中医药大学第一临床医学院,广州 510400
3.中南大学湘雅二医院,长沙 410011
文艺,女,32岁,博士研究生,主治医师。研究方向:中西医防治脾胃肝胆消化系疾病。
刘凤斌,博士生导师,教授,从事中医药防治消化系疾病研究,E-mail:liufb163@vip.163.com
纸质出版日期:2024-09-25,
收稿日期:2024-06-15,
移动端阅览
文艺,江晓涛,杨泽虹,等.健脾清热活血方对胃癌细胞的干预作用及机制研究[J].北京中医药,2024,43(9):973-980.
WEN Yi,JIANG Xiaotao,YANG Zehong,et al.Intervention effect of Jianpi Qingre Huoxue Formula on gastric cancer cells[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(09):973-980.
文艺,江晓涛,杨泽虹,等.健脾清热活血方对胃癌细胞的干预作用及机制研究[J].北京中医药,2024,43(9):973-980. DOI: 10.16025/j.1674-1307.2024.09.003.
WEN Yi,JIANG Xiaotao,YANG Zehong,et al.Intervention effect of Jianpi Qingre Huoxue Formula on gastric cancer cells[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(09):973-980. DOI: 10.16025/j.1674-1307.2024.09.003.
目的
2
探索健脾清热活血方(JQH)对胃癌细胞的干预作用。
方法
2
通过CCK-8、凋亡流式检测、划痕实验、裸鼠皮下成瘤试验,研究JQH对胃癌细胞的干预作用,并利用网络药理学获取其可能作用机制。
结果
2
经CCK-8检测,JQH干预组在24、48、72 h的增殖率均低于空白组;经流式细胞仪检测,JQH干预组凋亡细胞百分比高于空白组;经划痕实验,JQH干预组胃癌细胞24、48 h的愈合百分比(迁移能力)均低于空白组;JQH干预组裸鼠皮下瘤体的体积及重量均低于空白组,中、高剂量组抑瘤效果与5-Fu阳性药物对照组相当。网络药理学研究显示JQH可通过多靶点干预胃癌细胞,其作用机制可能涉及磷酸化、蛋白磷酸化、细胞增殖及凋亡的调控等功能,可通过调控PI3K/AKT通路抑癌。
结论
2
JQH可通过多途径、多通路影响胃癌细胞的增殖、迁移和凋亡。
Objective
2
To explore the intervention effect of Jianpi Qingre Huoxue Formula (JQH) on gastric cancer cells.
Methods
2
The intervention effect of JQH on gastric cancer cells was investigated using CCK-8 assays, apoptosis flow cytometry, scratch assays, and nude mouse subcutaneous tumor formation tests. Network pharmacology was employed to identify its potential mechanisms of action.
Results
2
After CCK-8 detection, the proliferation rate of JQH intervention group was lower than blank group at 24, 48 and 72 h. Flow cytometry showed that the percentage of apoptotic cells in JQH intervention group was higher than blank group. By scratch test, the healing percentage (migration ability) of gastric cancer cells in JQH intervention group at 24 and 48 h was lower than blank group. The volume and weight of subcutaneous tumor of nude mice in the JQH intervention group were lower than those in the blank group, the antitumor effect of medium and high dose groups was similar to that of 5-Fu group. Network pharmacology indicated that JQH could intervene in gastric cancer cells through multiple targets. Its mechanisms of action may involve regulation of phosphorylation, protein phosphorylation, cell proliferation, and apoptosis, and it may inhibit cancer by modulating the PI3K/AKT pathway.
Conclusion
2
JQH can affect the proliferation, migration and apoptosis of gastric cancer cells through multiple pathways and pathways.
胃癌健脾清热活血方抑癌作用信号通路
Gastric cancerJianpi Qingre Huoxue Formulaanticancer effectsignal pathways
刘瑞, 庞博, 侯炜,等. 中医“治未病”思想在肿瘤研究中的实践及思考[J]. 北京中医药,2018,37(12):1146-1148,1151.
谢晓妹, 冉静纯, 赵唯含, 等. 基于“虚瘀毒”理论的中医药 治疗慢性萎缩性胃炎的Meta分析[J]. 中华中医药学刊, 2020,38(2):108-114.
杨洋, 方霜霜, 独思静, 等. 基于OLGIM分期的慢性萎缩性胃炎证素特征分析[J]. 中国中西医结合消化杂志,2024,32(6):493-496.
李碧湘, 张小琴, 郑凯. 健脾解毒汤联合化疗治疗胃癌疗效及安全性研究[J]. 中华中医药学刊,2019,37(12):2833-2836.
杨国强, 闫强. 健脾解毒汤结合射频消融术治疗胃癌肝转移疗效研究[J]. 陕西中医,2019,40(11):1510-1512,1537.
安娜, 管福军, 周艳春,等. 健脾清毒汤对胃癌围手术期患者治疗的临床疗效研究[J]. 河北中医药学报,2019,34(1):22-24.
张亮亮,李根,杨帅,等. 网络药理学联合基因表达数据库芯片分析及分子对接技术探讨健脾清化化瘀汤治疗胃癌前病变的潜在机制 [J]. 北京中医药,2023,42(5): 501-507.
庄昆海, 李海文, 刘洪,等. 胃萎清颗粒治疗慢性萎缩性胃炎的临床研究[J]. 现代消化及介入诊疗,2018,23(4):479-483.
庄昆海, 李海文, 刘凤斌. 胃萎清对慢性萎缩性胃炎大鼠胃黏膜超微结构的影响[J]. 新中医,2018,50(7):4-7.
徐叔云, 卞如濂, 陈修. 药理实验方法学[M]. 北京:人民卫生出版社, 2003.
霍达, 任明, 宋春燕,等. 癌毒理论研究及其对癌肿辨证施治的指导[J]. 中国中医药现代远程教育,2018,16(18):66-69.
江晓涛,李培武,杨泽虹,等. 刘凤斌对慢性萎缩性胃炎“炎-癌”转化的病机探索与辨治思路 [J]. 广州中医药大学学报,2024,41(7):1880-1885.
张铮, 张培彤, 缪锐,等. 健运中州法治疗胰腺黏液性囊腺癌术后伴多部位转移1例[J]. 北京中医药,2024,43(5):573-575.
杨伟钦, 蒋凯林, 杨浩宇,等. 基于数据挖掘的刘凤斌教授治疗慢性萎缩性胃炎组方规律探究[J]. 辽宁中医药大学学报,2018,20(8):81-84.
黄远程, 黄超原, 梁怀枫,等. 慢性非萎缩性胃炎与慢性萎缩性胃炎证候、证素分布规律文献研究[J]. 中医杂志,2019,60(16):1417-1422.
黄远程,潘静琳,蒋凯林,等. 岭南地区慢性萎缩性胃炎证候、证素分布规律的文献研究[J]. 广州中医药大学学报,2019,36(10):1646-1650.
侯政昆,刘凤斌,李培武,等. 刘凤斌教授治疗慢性萎缩性胃炎的病例系列挖掘分析和经验总结[J]. 中国中药杂志,2015,40(11):2227-2234.
黄超原, 黄远程, 潘静琳,等. 广东省名中医刘凤斌教授辨治慢性萎缩性胃炎经验探讨[J]. 时珍国医国药,2018,29(12):3025-3028.
庄昆海. 基于“炎-癌链”探讨健脾清热活血法对慢性萎缩性胃炎的干预机制研究[D]. 广州:广州中医药大学,2017.
刘洪, 文艺, 侯政昆,等. 复方胃萎清治疗慢性萎缩性胃炎的网络药理学研究[J]. 中药材,2018,41(11):2650-2654.
WANG Z, DONG L, ZHEN Y, et al. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer[J]. Pak J Pharm Sci, 2016,29(5):1473-1482.
YU J, JI H, DONG X, et al. Apoptosis of human gastric carcinoma MGC-803 cells induced by a novel Astragalus membranaceus polysaccharide via intrinsic mitochondrial pathways[J]. Int J Biol Macromol,2019,126:811-819.
CAI T, ZHANG C, ZHAO Z, et al. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats[J]. Biomed Pharmacother,2018,104:291-299.
WU J, YU J, WANG J, et al. Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway[J]. Biomed Pharmacother,2018,100:176-183.
TIAN S, YU H. Atractylenolide II Inhibits proliferation, motility and induces apoptosis in human gastric carcinoma cell lines HGC-27 and AGS[J]. Molecules,2017,22(11):1-10.
陈继馨,袁成民,曹玉风. 中药莪术抗胃癌作用研究进展[J]. 中国中医药科技,2018,25(3):458-459.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构